Pill tested to tame lingering COVID misery
NCT ID NCT06437223
Summary
This small, completed study tested whether a daily pill called Xiflam could safely reduce the many symptoms of Long COVID. Sixteen people who had persistent health problems for at least 12 weeks after a COVID-19 infection took either Xiflam or a placebo pill for 12 weeks. The main goal was to see if the drug helped ease symptoms like fatigue, brain fog, and body aches, which patients reported on a severity scale.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LONG COVID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts Eye Research and Surgery Institution (MERSI)
Waltham, Massachusetts, 02451, United States
Conditions
Explore the condition pages connected to this study.